Cryofibrinogenemia and skin necrosis in a patient with diffuse large cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation

Bone Marrow Transplant. 2000 Dec;26(12):1343-5. doi: 10.1038/sj.bmt.1702678.

Abstract

A 34-year-old woman with diffuse mediastinal B cell large cell lymphoma presented 60 days after high-dose chemotherapy and autologous stem cell transplantation, and post-transplant immunotherapy with interleukin-2, with skin necrosis in the ears and extremities. Extensive work-up revealed the presence of cryofibrinogenemia and associated thrombotic vasculopathy. The patient was successfully treated with corticosteroids and therapeutic plasma exchange. However, she had recurrence of large cell lymphoma a few weeks later and died of progressive disease. Cryfibrinogenemia and skin necrosis may have occurred secondary to the imminent relapse, or as a rare complication of high-dose chemotherapy or treatment with interleukin-2.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Cryoglobulinemia / etiology*
  • Cryoglobulinemia / pathology
  • Cryoglobulins / adverse effects
  • Fatal Outcome
  • Female
  • Fibrinogens, Abnormal / adverse effects
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / complications*
  • Lymphoma, Large B-Cell, Diffuse / therapy
  • Necrosis
  • Recurrence
  • Skin Diseases / etiology*
  • Skin Diseases / pathology
  • Transplantation, Autologous

Substances

  • Cryoglobulins
  • Fibrinogens, Abnormal
  • cryofibrinogen